BioStock: Iconovo strengthens international intellectual property
2020 has been a year of intellectual property expansion for dry powder inhaler developer Iconovo. Much of that expansion has come within Sweden and the EU, but recently the company has received the notice of intention to grant a patent from the Chinese Patent Agency regarding Iconovo’s reservoir-based inhalation device, ICOres. The new patent will protect the technology used in many of Iconovo’s projects like the project concerning a generic version of Symbicort.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se